Vaccine

This paper discusses the recent study by Bansal et al. on the detection of spike protein in persons vaccinated with the Pfizer mRNA vaccine. The most significant finding is that spike protein is found on exosomes, that is, cell-derived vesicles, for at least four months after the second injection. This surprisingly long persistence raises the prospect of sustained inflammation within and damage to organs which

The messenger RNA (mRNA) from Pfizer’s COVID-19 vaccine is able to enter human liver cells and is converted ...

An unresolved issue of SARS-CoV-2 disease is that patients often remain positive for viral RNA as detected by PCR many weeks after the initial infection in the absence of evidence for viral replication. We show here that SARS-CoV-2 RNA can be reverse-transcribed ...

(NaturalHealth365) New research links genetic material in SARS-CoV-2 spike protein to gene sequence patented by Moderna years before pandemic.

The lab leak theory as the origin of COVID became even more plausible when scientists on Thursday announced they had found genetic material owned by Moderna in the virus' spike protein.

Sayer Ji reports on a newly published study which confirms that there is a plausible mechanism of action whereby the Covid-19 mRNA technology found within the Pfizer 'vaccine' may change the DNA of human cells, despite previous attempts by a wide range of government, corporate, and media organizations to dismiss this concern as "conspiracy theory" or "harmful misinformation." Links referenced in this video: “Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line: https://www.mdpi.com/1467-3045/44/3/73/htmReverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166107/SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743078/February 07, 2022 : Summary of Terrorism Threat to the U.S. Homeland: https://www.dhs.gov/ntas/advisory/national-terrorism-advisory-system-bulletin-february-07-2022No Sex Required: Body Cells Transfer Genetic Info Directly Into Sperm Cells, Amazing Study Finds: https://www.greenmedinfo.com/blog/no-sex-required-body-cells-transfer-genetic-info-directly-sperm-cells-amazingBREAKING: PBS's News Hour Hit Piece Against Sayer Ji, Dr. Mercola & Dr. Tenpenny EXPOSED: https://besovereign.com/greenmedinfo/greenmedinfo?recording_id=786Act Now America: Ask Key Congressmen To Formally Investigate the CDC’s Conduct During COVID-19: https://standforhealthfreedom.com/action/investigate-the-cdc/

Two U.S. agencies have been quietly studying neurological problems that have appeared in people who have had COVID-19 vaccines

Blood clots have emerged as the common factor unifying many of the symptoms of COVID-19. Researchers in Germany have discovered that the virus changes the size and stiffness of red and white blood cells in the human body. Moreover, these changes can last for months, possibly explaining the seemingly never-ending symptoms of COVID-19. In December of... View Article

(NaturalHealth365) Why has China not administered mRNA shots to its citizens? Do they know something that the rest of the world does not?

Pericarditis after vaccination, possible inadvertent intravenous administration. Useful links as discussed in this video, https://www.react19.org/ https://www.youtube.com/watch?v=aebtcTi7EaA https://www.youtube.com/channel/UC4eegkSVzV56kTrSpvL6BKQ Rally in DC next month https://www.realnotrare.com Messages from Kyle Also a lot of people have been asking about my supplements and Ivermectin. Here are some good studies on the benefits. Ivermectin - https://pubmed.ncbi.nlm.nih.gov/32871846/ Star Anise / Flavonoids - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271800/

Anna Foster is an embalmer with 11 years of experience in Carrollton, MO. She speaks out for the first time in this exclusive interview. The big news is that she found the unusual clots in 93% of the

(NaturalHealth365) Worldwide data sheds light on worrying possibility of COVID jab-induced immune system destruction.

Get the latest statistics on COVID-19 vaccines adverse events reported to VAERS website here.

All About the 0micron \/ariant

COVID vaccines are “irreversible and potentially permanently damaging,” says Dr. Robert Malone, who explains why 16,000 physicians and medical scientists around the world signed a declaration publicly declaring healthy children should not be vaccinated for COVID-19.

It is not normal for young athletes to suffer cardiac arrest or death while playing sport, but most of these come shortly after a COVID shot.

It is not normal for young athletes to suffer cardiac arrest or death while playing sport, but most of these come shortly after a COVID shot.

COVID sentiment is changing among top ranks in the U.S. and Europe through the Chinese are continuing to close up cities, shut down vital ports (threatening the world’s supply chain with a huge shock), and believe it or not, are putting their citizens in little boxes. However, talking about a sea of COVID change, the... View Article

Post Doctoral Researcher

(NaturalHealth365) In an editorial published in BMJ, Peter Doshi and colleagues demand immediate release of COIVD shot data.

Joining me today is Brook Jackson, the Pfizer whistleblower who recently spoke with the British Medical Journal revealing documented safety concerns that directly undermine the trial data efficacy. Br...

Dr Peter Doshi, associate editor of the BMJ, exposes the total lack of scientific process behind the development and roll out Covid vaccines in a meeting called by Senator Ron Johnson on the topic of ...

The government-media-pharma gang is lying, and they will never stop lying to cancer patients specifically and the rest of us in general. Do a Google search on Cancer and COVID vaccines, and you will see the number of organizations all saying the same thing. As far as the eye can see, we have pronouncements that... View Article

Cell Discovery - Comprehensive investigations revealed consistent pathophysiological alterations after...

(NaturalHealth365) A recent study from Wuhan, China, reveals COVID shot triggers physiological changes in humans, weakens the immune system.

(NaturalHealth365) Analysis of data from 145 countries shows causal relationship between COVID jab rollout and increase in deaths and cases.

Background The incidence of SARS-CoV-2 infection, including among those who have received 2 doses of COVID-19 vaccines, has increased substantially since Omicron was first identified in the province of Ontario, Canada. Methods Applying the test-negative design to linked provincial data, we estimated vaccine effectiveness against infection (irrespective of symptoms or severity) caused by Omicron or Delta between November 22 and December 19, 2021. We included individuals who had received at least 2 COVID-19 vaccine doses (with at least 1 mRNA vaccine dose for the primary series) and used multivariable logistic regression to estimate the effectiveness of two or three doses by time since the latest dose. Results We included 3,442 Omicron-positive cases, 9,201 Delta-positive cases, and 471,545 test-negative controls. After 2 doses of COVID-19 vaccine, vaccine effectiveness against Delta infection declined steadily over time but recovered to 93% (95%CI, 92-94%) ≥7 days after receiving an mRNA vaccine for the third dose. In contrast, receipt of 2 doses of COVID-19 vaccines was not protective against Omicron. Vaccine effectiveness against Omicron was 37% (95%CI, 19-50%) ≥7 days after receiving an mRNA vaccine for the third dose. Conclusions Two doses of COVID-19 vaccines are unlikely to protect against infection by Omicron. A third dose provides some protection in the immediate term, but substantially less than against Delta. Our results may be confounded by behaviours that we were unable to account for in our analyses. Further research is needed to examine protection against severe outcomes. ### Competing Interest Statement K.W. is CEO of CANImmunize and serves on the data safety board for the Medicago COVID-19 vaccine trial. The other authors declare no conflicts of interest. ### Funding Statement This work was supported by the Canadian Immunization Research Network (CIRN) through a grant from the Public Health Agency of Canada and the Canadian Institutes of Health Research (CNF 151944). This project was also supported by funding from the Public Health Agency of Canada, through the Vaccine Surveillance Reference Group and the COVID-19 Immunity Task Force. This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH). J.C.K. is supported by Clinician-Scientist Award from the University of Toronto Department of Family and Community Medicine. P.C.A. is supported by a Mid-Career Investigator Award from the Heart and Stroke Foundation. This work was supported by Public Health Ontario. This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC). This study was supported by the Ontario Health Data Platform (OHDP), a Province of Ontario initiative to support Ontarios ongoing response to COVID-19 and its related impacts. The study sponsors did not participate in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; or the decision to submit the manuscript for publication. Parts of this material are based on data and/or information compiled and provided by the Canadian Institute for Health Information (CIHI) and by Cancer Care Ontario (CCO). However, the analyses, conclusions, opinions and statements expressed herein are solely those of the authors, and do not reflect those of the funding or data sources; no endorsement by ICES, MOH, MLTC, OHDP, its partners, the Province of Ontario, CIHI or CCO is intended or should be inferred. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Section 45 of PHIPA authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of, the allocation of resources to or planning for all or part of the health system. Projects that use data collected by ICES under section 45 of PHIPA, and use no other data, are exempt from REB review. The use of the data in this project is authorized under section 45 and approved by ICES Privacy and Legal Office. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes The dataset from this study is held securely in coded form at ICES. While legal data sharing agreements between ICES and data providers (e.g., healthcare organizations and government) prohibit ICES from making the dataset publicly available, access may be granted to those who meet pre-specified criteria for confidential access, available at www.ices.on.ca/DAS (email: das@ices.on.ca).